14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $51.99 $51.99 Friday, 27th Jan 2023 CCXI stock ended at $51.99. During the day the stock fluctuated 0% from a day low at $51.99 to a day high of $51.99.
90 days $51.99 $51.99
52 weeks $14.95 $52.00

Historical ChemoCentryx prices

Date Open High Low Close Volume
Nov 16, 2021 $39.42 $39.99 $38.08 $38.61 1 088 092
Nov 15, 2021 $39.53 $40.22 $38.86 $39.76 1 268 130
Nov 12, 2021 $38.71 $39.75 $38.32 $39.65 1 209 438
Nov 11, 2021 $37.99 $39.32 $37.80 $38.61 815 354
Nov 10, 2021 $39.01 $41.75 $37.84 $37.99 2 719 369
Nov 09, 2021 $39.42 $39.46 $37.43 $38.02 1 201 301
Nov 08, 2021 $39.75 $40.13 $38.34 $39.37 1 217 294
Nov 05, 2021 $39.38 $40.50 $38.09 $40.15 1 587 542
Nov 04, 2021 $39.81 $40.39 $38.00 $38.77 1 517 919
Nov 03, 2021 $37.20 $39.15 $36.53 $38.99 1 842 074
Nov 02, 2021 $36.61 $37.39 $35.64 $37.00 1 291 150
Nov 01, 2021 $35.44 $36.88 $35.21 $36.41 1 737 937
Oct 29, 2021 $34.11 $35.30 $34.02 $34.81 1 086 114
Oct 28, 2021 $32.80 $34.44 $32.71 $34.38 1 215 550
Oct 27, 2021 $33.57 $33.87 $32.56 $32.63 1 121 369
Oct 26, 2021 $34.95 $35.00 $33.21 $33.72 1 504 991
Oct 25, 2021 $34.49 $35.01 $33.92 $34.97 1 233 444
Oct 22, 2021 $34.29 $35.84 $33.55 $34.57 1 997 106
Oct 21, 2021 $34.70 $36.01 $34.59 $35.01 1 435 942
Oct 20, 2021 $33.60 $35.64 $33.55 $34.85 1 925 381
Oct 19, 2021 $32.55 $34.47 $31.77 $33.65 2 499 161
Oct 18, 2021 $34.64 $34.86 $31.72 $32.43 4 985 245
Oct 15, 2021 $36.53 $36.91 $34.37 $34.47 3 823 650
Oct 14, 2021 $37.40 $38.49 $36.43 $37.08 3 592 859
Oct 13, 2021 $35.50 $37.22 $34.61 $36.91 3 893 571
Click to get the best stock tips daily for free!

About ChemoCentryx

ChemoCentryx ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of... CCXI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT